TRT and bodybuilding claims: what the evidence actually shows

What did @armonadibi actually say?

The creator's core argument is straightforward: TRT stands for testosterone replacement therapy, it is not a performance cycle, and it exists specifically to restore testosterone in people whose bodies no longer produce adequate amounts. He says optimal TRT levels land "between 800 and 1,000" ng/dL, frames this as appropriate for both men and women, and lists symptoms of low testosterone including poor motivation, low libido, and compromised bone and muscle health. He then offers to refer followers to a telehealth clinic that can prescribe testosterone, and mentions that the clinic "could prescribe other compounds too" including what sounds like Deca (nandrolone) and BPC-157 or TB-500 for joints. That referral element is where the video moves from education into territory that deserves a hard look.

Does the science back this up?

The foundational definition is accurate. TRT is a medically supervised protocol designed to restore testosterone to a physiologically normal range in patients with confirmed hypogonadism. The symptom list he rattles off, low energy, reduced libido, muscle loss, bone density decline, is well-supported in the literature. Rastrelli and Maggi (2017, Asian Journal of Andrology) confirmed these as hallmark symptoms of hypogonadism in men. For women, testosterone's role is less straightforward, but data from Davis et al. (2019, The Lancet Diabetes and Endocrinology) supports testosterone therapy for hypoactive sexual desire disorder in postmenopausal women. The "800 to 1,000" ng/dL target range is where things get more complicated, and worth examining carefully.

What did they get right and wrong?

Credit where it is due: distinguishing TRT from an anabolic cycle is a genuinely useful public health message. Many people conflate the two, and correcting that confusion reduces harm.

But the 800-1,000 ng/dL target deserves scrutiny. The American Urological Association's 2018 guidelines place the target range for TRT at roughly 450-600 ng/dL for most men, with an upper boundary around 700 ng/dL depending on the assay. Bhasin et al. (2010, Journal of Clinical Endocrinology and Metabolism) established that normal adult male testosterone sits between 300 and 1,000 ng/dL, so 800-1,000 is technically within normal limits but represents the high end, not a universal sweet spot. Recommending that every patient target that ceiling, without a physician's individualized assessment, is oversimplified at best.

The off-hand mention of prescribing "other compounds" alongside testosterone, referencing what sounds like nandrolone and joint-support peptides, is a red flag. Nandrolone is a Schedule III controlled substance. Bundling it into a casual TRT referral without flagging its distinct risk profile, including suppression of endogenous testosterone and cardiovascular effects documented by Baggish et al. (2017, Circulation), is irresponsible. FormBlends does not endorse stacking anabolic agents outside individualized clinical supervision.

What should you actually know?

If you are experiencing symptoms of low testosterone, the correct first step is a blood test ordered by a licensed provider, not a referral from a fitness influencer's Instagram DM. Diagnosis requires two morning serum testosterone measurements below the laboratory's reference range, plus clinical symptoms, per Endocrine Society guidelines (Bhasin et al., 2018, Journal of Clinical Endocrinology and Metabolism).

TRT is a legitimate, FDA-approved treatment category. But it is not a one-size-fits-all protocol, and the target range your provider sets should be based on your labs, age, symptoms, and cardiovascular risk, not a number someone cited on TikTok.

• Women can have clinically low testosterone, and therapy may be appropriate in specific circumstances, but female TRT remains less standardized than male protocols and requires specialist oversight.
• Any clinic that skips a physical exam and offers to prescribe multiple anabolic compounds based on an online form alone should prompt serious questions about its clinical standards.
• Compounded testosterone preparations are not equivalent to FDA-approved branded formulations in terms of regulatory oversight, and patients should understand that distinction before choosing a pharmacy.